Patient Reported Outcomes for Bladder Management Strategies in Spinal Cord Injury (NBRG-PCORI)

November 3, 2021 updated by: Jeremy Myers, University of Utah
The investigators goal is to create a better understanding of patient reported outcomes for bladder management strategies (clean intermittent catheterization (CIC), indwelling catheter (IDC) and bladder surgery.

Study Overview

Detailed Description

Our study is a longitudinal observational study between bladder management strategies, comparing outcomes measured by patient reported questionnaires.

Study Type

Observational

Enrollment (Actual)

1479

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan
    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota
    • Utah
      • Salt Lake City, Utah, United States, 84132
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants with neurogenic bladder with urinary issues and currently being managed by one/ any of various bladder management treatments (clean intermittent catheterization, indwelling catheter, voiding or bladder surgery).

Description

Inclusion Criteria:

  • Participants with acquired spinal cord injury
  • Participants with neurogenic bladder
  • Participants must be undergoing or starting at least one of the following bladder management treatments at the time of enrollment. a) Clean intermittent catheterization (CIC) b) Have an indwelling catheter (IDC) c) Spontaneous voiding, and d) Have undergone bladder surgery
  • Age 18 or older
  • Willingness and ability to comply with study engagement
  • Able to provide consent

Exclusion Criteria:

  • Degenerative spinal cord issues, such as multiple sclerosis, neuromuscular dysfunction
  • Congenital spinal cord issues, such as spina bifida, myelomeningocele, or cerebral palsy
  • Participants that belong to a vulnerable population (pregnant, prisoners, mentally handicapped, etc)
  • Participants less than 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Clean Intermittent Catheterization
Participants performing intermittent catheterization of their bladder, having not had augmentation cystoplasty or creation of a catheterizable channel
Clean intermittent self catheterization is a standard of care.
Indwelling Catheter
Participants utilizing an Foley catheter or a suprapubic tube (cystostomy)
Indwelling catheterization is a standard of care.
Surgery
Undergoing any of the following surgeries: augmentation cystoplasty with or without a catheterizable channel, creation of catheterizable channel alone, urinary diversion (conduit or continent catheterizable pouch)
Bladder surgery is a standard of care.
Voiding
Participants with volitional control, voiding into diapers or a condom catheter via crede, valsalva, or spontaneous leakage
Voiding spontaneously is a standard of care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurogenic Bladder Symptom Score (NBSS): comparing change in: CIC, IDC, Voiding, and Surgery
Time Frame: Baseline and 1 year longitudinal follow up
The NBSS quantifies bladder symptoms
Baseline and 1 year longitudinal follow up
The Spinal Cord Injury Quality of Life Measurement System Bladder Management Difficulties (SCI-QOL Difficulties): comparing change in: CIC, IDC, Voiding, and Surgery
Time Frame: Baseline and 1 year longitudinal follow up
The SCI-QoL Difficulties assesses feelings and psychosocial impact of bladder symptoms
Baseline and 1 year longitudinal follow up
The Spinal Cord Injury Quality of Life Measurement System Bladder Complications (SCI-QOL Complications): comparing change in: CIC, IDC, Voiding, and Surgery
Time Frame: Baseline and 1 year longitudinal follow up
The SCI-QoL Complications assesses degree of bladder complications their psychosocial impact
Baseline and 1 year longitudinal follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NBSS Incontinence subdomain
Time Frame: Baseline and 1 year longitudinal follow up
The Incontinence subdomain measures degree of incontinence
Baseline and 1 year longitudinal follow up
NBSS Storage and Voiding subdomain
Time Frame: Baseline and 1 year longitudinal follow up
The Storage and Voiding subdomain measures symptoms related to frequency and emptying of the bladder
Baseline and 1 year longitudinal follow up
NBSS Consequences subdomain
Time Frame: Baseline and 1 year longitudinal follow up
The Consequences subdomain measures bladder related complications
Baseline and 1 year longitudinal follow up
NBSS QoL Satisfaction
Time Frame: Baseline and 1 year longitudinal follow up
The final question of the NBSS assesses overall satisfaction with the urinary system
Baseline and 1 year longitudinal follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeremy O Myers, MD, University of Utah School of Medicine - Urology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

June 30, 2018

Study Registration Dates

First Submitted

November 13, 2015

First Submitted That Met QC Criteria

November 25, 2015

First Posted (Estimate)

November 26, 2015

Study Record Updates

Last Update Posted (Actual)

November 9, 2021

Last Update Submitted That Met QC Criteria

November 3, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Clean Intermittent Catheterization

3
Subscribe